Stock Events

NanoVibronix 

$1.12
54
-$0.06-5.08% Tuesday 21:00

Statistics

Day High
-
Day Low
-
52W High
4.48
52W Low
0.73
Volume
0
Avg. Volume
244,760
Mkt Cap
2.29M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

15AprExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q2 2023
Q3 2023
Next
-0.65
-0.43
-0.22
0
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NAOV. It's not an investment recommendation.

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Elmsford, New York and currently employs 8 full-time employees. The firm's products include PainShield, WoundShield and UroShield. Its products under development include Renooskin and Endotrachshield. The firm's principal research and development activities are conducted in Israel, through its subsidiary, NanoVibronix (Israel 2003) Ltd. The firm operates in the United States, Europe and India, among others. The PainShield is a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. The firm's WoundShield system is a patch-based therapeutic ultrasound device that facilitates tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation.
Show more...
CEO
Brian Murphy
Employees
11
Country
US
ISIN
US63008J1088
WKN
000A2QB7C

Listings